Wehrheim, Germany

Wolfgang P Brade


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wolfgang P. Brade: Innovator in Pharmaceutical Lyophilization

Introduction

Wolfgang P. Brade is a notable inventor based in Wehrheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative approaches to drug formulation. His expertise is demonstrated by his patent focused on a specific lyophilizate formulation that improves the efficacy and safety of cancer treatment.

Latest Patents

Wolfgang P. Brade holds one patent titled "Ifosfamide-mesna lyophilizate and process for its preparation." This patent outlines a lyophilizate that primarily consists of ifosfamide, a chemotherapeutic agent, combined with 0.1-1.0 parts by weight of mesna and 0.1 to 17 parts by weight of hexitol. The innovative aspect of this product is its method of preparation, which involves freeze drying an aqueous or aqueous-ethanolic solution of ifosfamide and mesna, resulting in a more stable and effective formulation for patients undergoing treatment.

Career Highlights

Wolfgang P. Brade has dedicated his career to advancing pharmaceutical technologies. He is currently associated with Asta Pharma Aktiengesellschaft, a renowned company in the pharmaceutical sector. His work has contributed to the development of safer and more reliable therapeutic options for patients, making a tangible difference in the field of oncology.

Collaborations

Throughout his career, Wolfgang has collaborated with esteemed colleagues, including Dieter Sauerbier and Otto Isaac. These partnerships have fostered a collaborative environment for innovation and have led to the successful development of critical pharmaceutical solutions that enhance patient care.

Conclusion

Wolfgang P. Brade exemplifies the role of an inventor who continually seeks to improve pharmaceuticals for better patient outcomes. With his patented innovative formulation and valuable partnerships, he remains a key figure in the ongoing quest for advancements in cancer treatment. His contributions are paving the way for future innovations that could revolutionize the healthcare sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…